Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 1997

View Archived Issues

Recordati announces 1996 consolidated results

LifeTECH Corp. reports results for fiscal year 1996 and first quarter 1997

Cel-Sci six-month clinical update

EntreMed reports fiscal 1996 year-end results and receives U.S. patent

Biomira announces fourth-quarter and 1996 results

Imutec Pharma announces third-quarter results

Ribozyme Pharmaceuticals reports fourth-quarter and year-end financial results

Interferon Sciences reports 1996 operating results and clinical status update

OXIS International reports fiscal year-end results

Aquila Biopharmaceuticals reports fourth-quarter and 1996 year-end financial results

Cobalt porphyrins for obesity from Warner-Lambert

Novel antiemetic reported by Dainippon

Mitsubishi Chemical describes thrombin inhibitors

PGE2 agonists/antagonists from Ono

T-686 inhibits PAI-1 and development of atherosclerotic lesions

Inogatran exerts selective inhibition of thrombin in vitro

Taiho claims nitroimidazoles with antiangiogenic and contrast-enhancing effects

Chronic MK-677 increases GH and IGF-I in dogs

Clinical comparison of cromolyn and furosemide in asthmatics

Gene Logic/Johns Hopkins collaborate on schizophrenia and depression gene discovery

Eagle licenses biotin technology from University of Washington

Genes involved in marijuana abuse

Human skin equivalent approved in Canada

Component of olive oil demonstrates antioxidant and lipoxygenase-inhibitory effects

Hybridon receives clearance to initiate further GEM-132 trials

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

Nigella sativa plant extract exerts antiangiogenic activity

Triangle Pharmaceuticals exercises option to acquire MKC-442

RPR's Tilade approved for pediatric use

Pharmacia & Upjohn's Rescriptor cleared by FDA

Connetics commences phase III trial for betamethasone mousse

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...